Global Retinoblastoma Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: G350A56357ABEN
QYResearch

Abstracts

This report focuses on the global Retinoblastoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinoblastoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Baxter
• Bristol-Myers Squibb
• GlaxoSmithKline
• Spectrum Pharmaceuticals
• BioLineRx
• Cellceutix
• Icon Bioscience
• Neotropix
• RXi Pharmaceuticals
• Recombio

Market segment by Type, the product can be split into

• Congenital (Hereditary) Retinoblastoma
• Sporadic (Non-Hereditary) Retinoblastoma

Market segment by Application, split into

• Hospitals
• Cancer Institutes
• Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Retinoblastoma Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Retinoblastoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Retinoblastoma Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinoblastoma Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Retinoblastoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Congenital (Hereditary) Retinoblastoma
  1.4.3 Sporadic (Non-Hereditary) Retinoblastoma
1.5 Market by Application
  1.5.1 Global Retinoblastoma Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Cancer Institutes
  1.5.4 Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Retinoblastoma Treatment Market Perspective (2015-2026)
2.2 Retinoblastoma Treatment Growth Trends by Regions
  2.2.1 Retinoblastoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Retinoblastoma Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Retinoblastoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Retinoblastoma Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Retinoblastoma Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Retinoblastoma Treatment Players by Market Size
  3.1.1 Global Top Retinoblastoma Treatment Players by Revenue (2015-2020)
  3.1.2 Global Retinoblastoma Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Retinoblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinoblastoma Treatment Market Concentration Ratio
  3.2.1 Global Retinoblastoma Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Retinoblastoma Treatment Revenue in 2019
3.3 Retinoblastoma Treatment Key Players Head office and Area Served
3.4 Key Players Retinoblastoma Treatment Product Solution and Service
3.5 Date of Enter into Retinoblastoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Retinoblastoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Retinoblastoma Treatment Forecasted Market Size by Type (2021-2026)

5 RETINOBLASTOMA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Retinoblastoma Treatment Market Size by Application (2015-2020)
5.2 Global Retinoblastoma Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Retinoblastoma Treatment Market Size (2015-2020)
6.2 Retinoblastoma Treatment Key Players in North America (2019-2020)
6.3 North America Retinoblastoma Treatment Market Size by Type (2015-2020)
6.4 North America Retinoblastoma Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Retinoblastoma Treatment Market Size (2015-2020)
7.2 Retinoblastoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Retinoblastoma Treatment Market Size by Type (2015-2020)
7.4 Europe Retinoblastoma Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Retinoblastoma Treatment Market Size (2015-2020)
8.2 Retinoblastoma Treatment Key Players in China (2019-2020)
8.3 China Retinoblastoma Treatment Market Size by Type (2015-2020)
8.4 China Retinoblastoma Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Retinoblastoma Treatment Market Size (2015-2020)
9.2 Retinoblastoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Retinoblastoma Treatment Market Size by Type (2015-2020)
9.4 Japan Retinoblastoma Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Retinoblastoma Treatment Market Size (2015-2020)
10.2 Retinoblastoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retinoblastoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Retinoblastoma Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Retinoblastoma Treatment Market Size (2015-2020)
11.2 Retinoblastoma Treatment Key Players in India (2019-2020)
11.3 India Retinoblastoma Treatment Market Size by Type (2015-2020)
11.4 India Retinoblastoma Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Retinoblastoma Treatment Market Size (2015-2020)
12.2 Retinoblastoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Retinoblastoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Retinoblastoma Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Baxter
  13.1.1 Baxter Company Details
  13.1.2 Baxter Business Overview and Its Total Revenue
  13.1.3 Baxter Retinoblastoma Treatment Introduction
  13.1.4 Baxter Revenue in Retinoblastoma Treatment Business (2015-2020))
  13.1.5 Baxter Recent Development
13.2 Bristol-Myers Squibb
  13.2.1 Bristol-Myers Squibb Company Details
  13.2.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.2.3 Bristol-Myers Squibb Retinoblastoma Treatment Introduction
  13.2.4 Bristol-Myers Squibb Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.2.5 Bristol-Myers Squibb Recent Development
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Details
  13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.3.3 GlaxoSmithKline Retinoblastoma Treatment Introduction
  13.3.4 GlaxoSmithKline Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.3.5 GlaxoSmithKline Recent Development
13.4 Spectrum Pharmaceuticals
  13.4.1 Spectrum Pharmaceuticals Company Details
  13.4.2 Spectrum Pharmaceuticals Business Overview and Its Total Revenue
  13.4.3 Spectrum Pharmaceuticals Retinoblastoma Treatment Introduction
  13.4.4 Spectrum Pharmaceuticals Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.4.5 Spectrum Pharmaceuticals Recent Development
13.5 BioLineRx
  13.5.1 BioLineRx Company Details
  13.5.2 BioLineRx Business Overview and Its Total Revenue
  13.5.3 BioLineRx Retinoblastoma Treatment Introduction
  13.5.4 BioLineRx Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.5.5 BioLineRx Recent Development
13.6 Cellceutix
  13.6.1 Cellceutix Company Details
  13.6.2 Cellceutix Business Overview and Its Total Revenue
  13.6.3 Cellceutix Retinoblastoma Treatment Introduction
  13.6.4 Cellceutix Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.6.5 Cellceutix Recent Development
13.7 Icon Bioscience
  13.7.1 Icon Bioscience Company Details
  13.7.2 Icon Bioscience Business Overview and Its Total Revenue
  13.7.3 Icon Bioscience Retinoblastoma Treatment Introduction
  13.7.4 Icon Bioscience Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.7.5 Icon Bioscience Recent Development
13.8 Neotropix
  13.8.1 Neotropix Company Details
  13.8.2 Neotropix Business Overview and Its Total Revenue
  13.8.3 Neotropix Retinoblastoma Treatment Introduction
  13.8.4 Neotropix Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.8.5 Neotropix Recent Development
13.9 RXi Pharmaceuticals
  13.9.1 RXi Pharmaceuticals Company Details
  13.9.2 RXi Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 RXi Pharmaceuticals Retinoblastoma Treatment Introduction
  13.9.4 RXi Pharmaceuticals Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.9.5 RXi Pharmaceuticals Recent Development
13.10 Recombio
  13.10.1 Recombio Company Details
  13.10.2 Recombio Business Overview and Its Total Revenue
  13.10.3 Recombio Retinoblastoma Treatment Introduction
  13.10.4 Recombio Revenue in Retinoblastoma Treatment Business (2015-2020)
  13.10.5 Recombio Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Retinoblastoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Retinoblastoma Treatment Revenue
Table 3. Ranking of Global Top Retinoblastoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinoblastoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Congenital (Hereditary) Retinoblastoma
Table 6. Key Players of Sporadic (Non-Hereditary) Retinoblastoma
Table 7. Global Retinoblastoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Retinoblastoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Retinoblastoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Retinoblastoma Treatment Market Share by Regions (2015-2020)
Table 11. Global Retinoblastoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Retinoblastoma Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Retinoblastoma Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Retinoblastoma Treatment Players
Table 18. Global Retinoblastoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Retinoblastoma Treatment Market Share by Players (2015-2020)
Table 20. Global Top Retinoblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinoblastoma Treatment as of 2019)
Table 21. Global Retinoblastoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinoblastoma Treatment Product Solution and Service
Table 24. Date of Enter into Retinoblastoma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinoblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Retinoblastoma Treatment Market Size Share by Type (2015-2020)
Table 28. Global Retinoblastoma Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Retinoblastoma Treatment Market Size Share by Application (2015-2020)
Table 30. Global Retinoblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Retinoblastoma Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Retinoblastoma Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Retinoblastoma Treatment Market Share (2019-2020)
Table 34. North America Retinoblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Retinoblastoma Treatment Market Share by Type (2015-2020)
Table 36. North America Retinoblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Retinoblastoma Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Retinoblastoma Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Retinoblastoma Treatment Market Share (2019-2020)
Table 40. Europe Retinoblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Retinoblastoma Treatment Market Share by Type (2015-2020)
Table 42. Europe Retinoblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Retinoblastoma Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Retinoblastoma Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Retinoblastoma Treatment Market Share (2019-2020)
Table 46. China Retinoblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Retinoblastoma Treatment Market Share by Type (2015-2020)
Table 48. China Retinoblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Retinoblastoma Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Retinoblastoma Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Retinoblastoma Treatment Market Share (2019-2020)
Table 52. Japan Retinoblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Retinoblastoma Treatment Market Share by Type (2015-2020)
Table 54. Japan Retinoblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Retinoblastoma Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Retinoblastoma Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Retinoblastoma Treatment Market Share (2019-2020)
Table 58. Southeast Asia Retinoblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Retinoblastoma Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Retinoblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Retinoblastoma Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Retinoblastoma Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Retinoblastoma Treatment Market Share (2019-2020)
Table 64. India Retinoblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Retinoblastoma Treatment Market Share by Type (2015-2020)
Table 66. India Retinoblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Retinoblastoma Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Retinoblastoma Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Retinoblastoma Treatment Market Share (2019-2020)
Table 70. Central & South America Retinoblastoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Retinoblastoma Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Retinoblastoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Retinoblastoma Treatment Market Share by Application (2015-2020)
Table 74. Baxter Company Details
Table 75. Baxter Business Overview
Table 76. Baxter Product
Table 77. Baxter Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 78. Baxter Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Product
Table 82. Bristol-Myers Squibb Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Product
Table 87. GlaxoSmithKline Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline Recent Development
Table 89. Spectrum Pharmaceuticals Company Details
Table 90. Spectrum Pharmaceuticals Business Overview
Table 91. Spectrum Pharmaceuticals Product
Table 92. Spectrum Pharmaceuticals Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 93. Spectrum Pharmaceuticals Recent Development
Table 94. BioLineRx Company Details
Table 95. BioLineRx Business Overview
Table 96. BioLineRx Product
Table 97. BioLineRx Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 98. BioLineRx Recent Development
Table 99. Cellceutix Company Details
Table 100. Cellceutix Business Overview
Table 101. Cellceutix Product
Table 102. Cellceutix Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 103. Cellceutix Recent Development
Table 104. Icon Bioscience Company Details
Table 105. Icon Bioscience Business Overview
Table 106. Icon Bioscience Product
Table 107. Icon Bioscience Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 108. Icon Bioscience Recent Development
Table 109. Neotropix Business Overview
Table 110. Neotropix Product
Table 111. Neotropix Company Details
Table 112. Neotropix Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 113. Neotropix Recent Development
Table 114. RXi Pharmaceuticals Company Details
Table 115. RXi Pharmaceuticals Business Overview
Table 116. RXi Pharmaceuticals Product
Table 117. RXi Pharmaceuticals Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 118. RXi Pharmaceuticals Recent Development
Table 119. Recombio Company Details
Table 120. Recombio Business Overview
Table 121. Recombio Product
Table 122. Recombio Revenue in Retinoblastoma Treatment Business (2015-2020) (Million US$)
Table 123. Recombio Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Retinoblastoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Congenital (Hereditary) Retinoblastoma Features
Figure 3. Sporadic (Non-Hereditary) Retinoblastoma Features
Figure 4. Global Retinoblastoma Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Cancer Institutes Case Studies
Figure 7. Pharmacies Case Studies
Figure 8. Retinoblastoma Treatment Report Years Considered
Figure 9. Global Retinoblastoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Retinoblastoma Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Retinoblastoma Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Retinoblastoma Treatment Market Share by Players in 2019
Figure 14. Global Top Retinoblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinoblastoma Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Retinoblastoma Treatment Revenue in 2019
Figure 16. North America Retinoblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Retinoblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Retinoblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Retinoblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Retinoblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Retinoblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Retinoblastoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Baxter Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 25. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bristol-Myers Squibb Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 29. Spectrum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Spectrum Pharmaceuticals Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 31. BioLineRx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. BioLineRx Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 33. Cellceutix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Cellceutix Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 35. Icon Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Icon Bioscience Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 37. Neotropix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Neotropix Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 39. RXi Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. RXi Pharmaceuticals Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 41. Recombio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Recombio Revenue Growth Rate in Retinoblastoma Treatment Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed